Drugs / acetate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02542150 | Sep 2015 → Mar 2017 | — | University of Colorado, Denver | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01983046 Comparator | Sep 2013 → Feb 2014 | obesity disorder, type 2 diabetes mellitus | Maastricht University Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | acetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02542150 ↗ |
| Route | Intravenous | “acetate intravenously” PMID 31386214 ↗ Aug 2019 |